|
US5242904A
(en)
*
|
1987-06-05 |
1993-09-07 |
The Dupont Merck Pharmaceutical Company |
Peptide boronic acid inhibitors of trypsin-like proteases
|
|
DE3827340A1
(de)
*
|
1988-08-12 |
1990-02-15 |
Hoechst Ag |
Verwendung von (alpha)-aminoboronsaeure-derivaten zur prophylaxe und behandlung von viruserkrankungen
|
|
GB9017694D0
(en)
*
|
1990-08-13 |
1990-09-26 |
Sandoz Ltd |
Improvements in or relating to organic chemistry
|
|
CA2133658A1
(en)
*
|
1992-04-16 |
1993-10-28 |
Peter R. Bernstein |
Heterocyclic derivatives
|
|
WO1993021214A1
(en)
*
|
1992-04-16 |
1993-10-28 |
Zeneca Limited |
Alpha-aminoboronic acid peptides and their use as elastase inhibitors
|
|
US5442100A
(en)
*
|
1992-08-14 |
1995-08-15 |
The Procter & Gamble Company |
β-aminoalkyl and β-N-peptidylaminoalkyl boronic acids
|
|
FR2701951B1
(fr)
*
|
1993-02-24 |
1995-06-09 |
Adir |
Nouveaux derives peptidiques de l'acide boronique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
|
|
IL111175A0
(en)
*
|
1993-10-07 |
1994-12-29 |
Du Pont Merck Pharma |
Electrophilic peptide analogs as inhibitors of trypsin-like serine proteases and pharmaceutical compositions containing them
|
|
US6060462A
(en)
*
|
1993-10-20 |
2000-05-09 |
Dupont Pharmaceuticals Company |
Electrophilic peptide analogs as inhibitors of trypsin-like enzymes
|
|
US5693617A
(en)
*
|
1994-03-15 |
1997-12-02 |
Proscript, Inc. |
Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein
|
|
FR2718451B1
(fr)
*
|
1994-04-12 |
1996-05-10 |
Synthelabo |
Dérivés de peptides boroniques, leur préparation et leur application en thérapeutique.
|
|
US6083903A
(en)
*
|
1994-10-28 |
2000-07-04 |
Leukosite, Inc. |
Boronic ester and acid compounds, synthesis and uses
|
|
US5639739A
(en)
*
|
1995-03-24 |
1997-06-17 |
The Dupont Merck Pharmaceutical Company |
Imidazole containing aminoboronic acids
|
|
FR2739858B1
(fr)
*
|
1995-10-11 |
1997-11-14 |
Synthelabo |
Derives de n-sulfonyl- et n-sulfamoylpeptidylprolinamide, leur preparation et leur application en therapeutique
|
|
US6586615B1
(en)
*
|
2001-01-10 |
2003-07-01 |
Bristol-Myers Squibb Company |
α-aminoboronic acids prepared by novel synthetic methods
|
|
DK3078667T3
(en)
*
|
2001-01-25 |
2019-01-07 |
The United States Of America Represented By The Sec Dep Of Health And Human Services |
Formulation of boric acid compounds
|
|
US6933290B2
(en)
|
2001-05-30 |
2005-08-23 |
Novartis Ag |
2-{N-(2-amino-3-(heteroaryl or aryl)propionyl)-aminoacyl}-amino}-alkylboronic acid derivatives
|
|
US7112572B2
(en)
*
|
2002-09-09 |
2006-09-26 |
Trigen Limited |
Multivalent metal salts of boronic acids
|
|
US20050119226A1
(en)
*
|
2003-09-09 |
2005-06-02 |
Trigen Limited |
Methods for synthesizing organoboronic compounds and products thereof
|
|
AU2003263343A1
(en)
|
2002-09-09 |
2004-03-29 |
Trigen Limited |
Boronic acid salts ant their use in the treatment of thromobis
|
|
US20050282757A1
(en)
*
|
2002-09-09 |
2005-12-22 |
Trigen Limited |
Peptide boronic acid compounds useful in anticoagulation
|
|
US20060084592A1
(en)
*
|
2002-09-09 |
2006-04-20 |
Trigen Limited |
Peptide boronic acid inhibitors
|
|
US20050176651A1
(en)
*
|
2002-09-09 |
2005-08-11 |
Trigen Limited |
Peptide boronic acids useful in making salts thereof
|
|
US7576206B2
(en)
*
|
2003-08-14 |
2009-08-18 |
Cephalon, Inc. |
Proteasome inhibitors and methods of using the same
|
|
US7223745B2
(en)
|
2003-08-14 |
2007-05-29 |
Cephalon, Inc. |
Proteasome inhibitors and methods of using the same
|
|
GB0405272D0
(en)
*
|
2004-03-09 |
2004-04-21 |
Trigen Ltd |
Compounds
|
|
CA2859119A1
(en)
*
|
2004-03-30 |
2005-10-20 |
Millenium Pharmaceuticals, Inc. |
Synthesis of boronic ester and acid compounds
|
|
US7468383B2
(en)
|
2005-02-11 |
2008-12-23 |
Cephalon, Inc. |
Proteasome inhibitors and methods of using the same
|
|
US20070059382A1
(en)
*
|
2005-09-09 |
2007-03-15 |
Board Of Regents, Univ. And Comm. College System Of Nevada... |
Medical treatment of breast cancer with boric acid materials
|
|
CA2695082C
(en)
|
2007-08-06 |
2015-07-28 |
Millennium Pharmaceuticals, Inc. |
Peptide boronic acid and boronic ester compounds as proteasome inhibitors
|
|
US7838673B2
(en)
*
|
2007-10-16 |
2010-11-23 |
Millennium Pharmaceuticals, Inc. |
Proteasome inhibitors
|
|
US9212155B2
(en)
|
2008-03-19 |
2015-12-15 |
Aurimmed Pharma, Inc. |
Compounds advantageous in the treatment of central nervous system diseases and disorders
|
|
KR101672884B1
(ko)
|
2008-03-19 |
2016-11-04 |
오림드 파마, 인코포레이티드 |
중추신경계 질환 및 질병 치료에 유효한 신규 화합물
|
|
US10793515B2
(en)
|
2008-03-19 |
2020-10-06 |
Aurimmed Pharma, Inc. |
Compounds advantageous in the treatment of central nervous system diseases and disorders
|
|
US20090325903A1
(en)
|
2008-06-17 |
2009-12-31 |
Millennium Pharmaceuticals, Inc. |
Boronate ester compounds and pharmaceutical compositions thereof
|
|
AR075090A1
(es)
|
2008-09-29 |
2011-03-09 |
Millennium Pharm Inc |
Derivados de acido 1-amino-2-ciclobutiletilboronico inhibidores de proteosoma,utiles como agentes anticancerigenos, y composiciones farmaceuticas que los comprenden.
|
|
EP2344165A4
(en)
*
|
2008-10-01 |
2012-12-05 |
Reddys Lab Ltd Dr |
PHARMACEUTICAL COMPOSITIONS COMPRISING BORONIC ACID COMPOUNDS
|
|
EP2270019A1
(en)
|
2009-06-19 |
2011-01-05 |
LEK Pharmaceuticals d.d. |
New synthetic route for the preparation of alpha-amino boronic esters
|
|
JP2012530115A
(ja)
|
2009-06-19 |
2012-11-29 |
レツク・フアーマシユーテイカルズ・デー・デー |
置換アルカ−１−インを経由するα−アミノボロン酸誘導体の調製のための新規な合成経路
|
|
EP2280016A1
(en)
|
2009-07-27 |
2011-02-02 |
LEK Pharmaceuticals d.d. |
New synthetic route for the preparation of alpha-amino boronic esters via substituted alk-1-ynes
|
|
WO2011022502A1
(en)
|
2009-08-18 |
2011-02-24 |
Georgetown University |
Boronic acid compositions and methods related to cancer
|
|
WO2011087822A1
(en)
|
2009-12-22 |
2011-07-21 |
Cephalon, Inc. |
Proteasome inhibitors and processes for their preparation, purification and use
|
|
MX2012011298A
(es)
|
2010-03-31 |
2012-11-06 |
Millennium Pharm Inc |
Derivados del acido 1-amino-2-ciclopropiletilboronico.
|
|
US8962572B2
(en)
|
2010-10-05 |
2015-02-24 |
Fresenius Kabi Usa, Llc |
Bortezomib formulations
|
|
EP2819673B1
(en)
|
2012-03-02 |
2016-09-07 |
Dr. Reddy's Laboratories Ltd. |
Pharmaceutical compositions comprising boronic acid compounds
|
|
WO2014072985A1
(en)
|
2012-11-06 |
2014-05-15 |
Natco Pharma Limited |
Novel boronic acid derivatives as anti cancer agents
|
|
WO2014170628A1
(en)
|
2013-04-16 |
2014-10-23 |
Cipla Limited |
Process for the preparation of bortezomib mannitol ester
|
|
US10478445B2
(en)
|
2013-07-03 |
2019-11-19 |
Georgetown University |
Boronic acid derivatives of resveratrol for activating deacetylase enzymes
|
|
WO2015117136A1
(en)
|
2014-02-03 |
2015-08-06 |
Ohio State Innovation Foundation |
Boronic acid esters and pharmaceutical formulations thereof
|
|
SG11201609259VA
(en)
|
2014-05-20 |
2016-12-29 |
Millennium Pharm Inc |
Boron-containing proteasome inhibitors for use after primary cancer therapy
|
|
MA41505A
(fr)
|
2015-02-11 |
2017-12-19 |
Millennium Pharm Inc |
Nouvelle forme cristalline d'un inhibiteur de protéasome
|
|
WO2016146516A1
(en)
|
2015-03-17 |
2016-09-22 |
Leon-Nanodrugs Gmbh |
Nanoparticles comprising a stabilized boronic acid compound
|
|
US10144761B2
(en)
|
2015-06-19 |
2018-12-04 |
Hanlin Scientific Inc. |
Chiral specific boron-containing compounds and their use in treating cancer or amyloidosis
|
|
EA201990069A1
(ru)
|
2016-06-21 |
2019-06-28 |
ОРИОН ОФТАЛМОЛОДЖИ ЭлЭлСи |
Производные гетероциклического пролинамида
|
|
JP7164521B2
(ja)
|
2016-06-21 |
2022-11-01 |
オリオン・オフサルモロジー・エルエルシー |
炭素環式プロリンアミド誘導体
|